Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 7/20 | 0.67 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.54 |
| ▸ | DHODH | Q02127 | 1/20 | 0.52 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.49 |
| ▸ | CYP11B2 | P19099 | 6/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.44 |
| ▸ | GLA | P06280 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.44 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.43 |
| ▸ | HIPK2 | Q9H2X6 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17807971 | 0.97 | CYP11B1 (0.67) | CYP11B1CYP19A1DHODHGPR84CYP11B2 | |
| SCHEMBL30296752 | 0.97 | CYP11B1 (0.67) | CYP11B1CYP19A1DHODHGPR84CYP11B2 | |
| SCHEMBL17918051 | 0.97 | CYP11B1 (0.67) | CYP11B1CYP19A1DHODHGPR84CYP11B2 | |
| SCHEMBL19650642 | 0.97 | CYP11B1 (0.67) | CYP11B1CYP19A1DHODHGPR84CYP11B2 | |
| SCHEMBL24252242 | 0.96 | CYP11B1 (0.68) | CYP11B1CYP19A1DHODHGPR84CYP11B2 | |
| SCHEMBL17918052 | 0.96 | CYP11B1 (0.68) | CYP11B1CYP19A1DHODHGPR84CYP11B2 | |
| SCHEMBL30857455 | 0.96 | CYP11B1 (0.68) | CYP11B1CYP19A1DHODHGPR84CYP11B2 | |
| SCHEMBL24252593 | 0.96 | CYP11B1 (0.68) | CYP11B1CYP19A1DHODHGPR84CYP11B2 | |
| SCHEMBL24252590 | 0.94 | CYP11B1 (0.62) | CYP11B1CYP19A1DHODHGPR84CYP11B2 | |
| SCHEMBL19762057 | 0.94 | CYP11B1 (0.65) | CYP11B1CYP19A1DHODHGPR84CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3683212-B1 | COMPOUND HAVING PYRIMIDINE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT | HODOGAYA CHEMICAL CO LTD (JP) | 2025-11-05 | — | — | EP | disclosed |
| US-12221430-B2 | Compound having pyrimidine ring structure and organic electroluminescence device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2025-02-11 | — | — | US | disclosed |
| US-20200277272-A1 | COMPOUND HAVING PYRIMIDINE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENCE DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2020-09-03 | — | — | US | disclosed |
| US-20200277272-A1 | COMPOUND HAVING PYRIMIDINE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENCE DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2020-09-03 | — | — | US | disclosed |
| EP-3683212-A1 | COMPOUND HAVING PYRIMIDINE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT | Hodogaya Chemical Co., Ltd. (JP) | 2020-07-22 | — | — | EP | disclosed |
| CN-111094264-A | Compound having pyrimidine ring structure and organic electroluminescent element | 保土谷化学工业株式会社 | 2020-05-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200277272-A1 | COMPOUND HAVING PYRIMIDINE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENCE DEVICE | SLC29A1, ADORA1, SLC29A2 | CYP11B1 2487/4885CYP19A1 1296/4885DHODH 986/4885 |
| US-12221430-B2 | Compound having pyrimidine ring structure and organic electroluminescence device | SLC29A1, SLC29A2, ADORA1 | CYP11B1 2463/4885CYP19A1 1130/4885DHODH 773/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.